In a bold move, China's Ministry of Finance announced new measures affecting government procurement projects. When the budget for medical devices exceeds 45 million yuan (about $6.29 million), EU enterprises supplying imported products are now excluded from bidding—except for EU-funded enterprises operating in China. This measure applies to both single purchases and bulk orders, ensuring a level playing field in the procurement process.
For those EU-funded enterprises based in China, there’s still a chance to participate. However, if their products include imported devices, these can only account for up to 50% of the total contract value. Notably, state-owned-enterprise procurement remains outside the scope of these new rules.
The decision comes as a reciprocal response to earlier measures introduced by the European Commission on June 20, 2025, which raised barriers for Chinese firms in EU public procurement. A spokesperson from China's commerce ministry emphasized that, despite efforts to resolve differences through dialogue, the EU's protectionist barriers left China with little choice but to act. 🤝
This new development is a sign of evolving global trade dynamics, reminding us that international rules can shift quickly—much like the fast-paced lives and tech innovations that shape our world today. Stay tuned for more updates on these trade trends! 🚀
Reference(s):
China details curbs on EU medical device imports in govt procurement
cgtn.com
